alendronate has been researched along with Kidney Failure in 9 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with alendronate reduced the risk of clinical fractures to a similar degree in those with (OR: 0." | 2.73 | Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. ( Bauer, DC; Cauley, JA; Cummings, SR; Ensrud, KE; Hochberg, M; Ishani, A; Jamal, SA, 2007) |
| "etidronate) have been associated with acute renal failure." | 2.44 | Safety considerations with bisphosphonates for the treatment of osteoporosis. ( Civitelli, R; Emkey, R; Strampel, W, 2007) |
| "Alendronate treatment was discontinued and, while a suitable kidney donor was sought, the patient was treated for 6 months with teriparatide, which significantly reduced the osteomalacia." | 1.42 | Reversible Deterioration in Hypophosphatasia Caused by Renal Failure With Bisphosphonate Treatment. ( Collins, JF; Cundy, T; Dray, M; Fratzl-Zelman, N; Gamsjaeger, S; Klaushofer, K; Michigami, T; Paschalis, EP; Roschger, A; Roschger, P; Tachikawa, K, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Naganathar, N | 1 |
| Yau, W- | 1 |
| Mok, ZH | 1 |
| Tan, ZYF | 1 |
| Chew, STH | 1 |
| Cundy, T | 1 |
| Michigami, T | 1 |
| Tachikawa, K | 1 |
| Dray, M | 1 |
| Collins, JF | 1 |
| Paschalis, EP | 1 |
| Gamsjaeger, S | 1 |
| Roschger, A | 1 |
| Fratzl-Zelman, N | 1 |
| Roschger, P | 1 |
| Klaushofer, K | 1 |
| Matsui, I | 1 |
| Hamano, T | 1 |
| Mikami, S | 1 |
| Fujii, N | 1 |
| Takabatake, Y | 1 |
| Nagasawa, Y | 1 |
| Kawada, N | 1 |
| Ito, T | 1 |
| Rakugi, H | 1 |
| Imai, E | 1 |
| Isaka, Y | 1 |
| O'Neill, WC | 1 |
| Hannon, RA | 1 |
| Clowes, JA | 1 |
| Eagleton, AC | 1 |
| Al Hadari, A | 1 |
| Eastell, R | 1 |
| Blumsohn, A | 1 |
| Dejardin, A | 1 |
| Devogelaer, JP | 1 |
| Goffin, E | 1 |
| Jamal, SA | 1 |
| Bauer, DC | 1 |
| Ensrud, KE | 1 |
| Cauley, JA | 1 |
| Hochberg, M | 1 |
| Ishani, A | 1 |
| Cummings, SR | 1 |
| Strampel, W | 1 |
| Emkey, R | 1 |
| Civitelli, R | 1 |
| Ott, SM | 1 |
| Drueke, T | 1 |
| Elder, G | 1 |
| Fukagawa, M | 1 |
| Jorgetti, V | 1 |
| Langman, CB | 1 |
| Moe, S | 1 |
| McCann, L | 1 |
| Wang, AY | 1 |
| Weisinger, J | 1 |
| Wheeler, D | 1 |
1 review available for alendronate and Kidney Failure
| Article | Year |
|---|---|
Safety considerations with bisphosphonates for the treatment of osteoporosis.
Topics: Acute-Phase Reaction; Administration, Oral; Alendronate; Bone Density Conservation Agents; Diphospho | 2007 |
1 trial available for alendronate and Kidney Failure
| Article | Year |
|---|---|
Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Creatinine; Fe | 2007 |
7 other studies available for alendronate and Kidney Failure
| Article | Year |
|---|---|
Alendronate use in older patients with reduced renal function: challenges and opportunities in clinical practice.
Topics: Aged; Alendronate; Diphosphonates; Humans; Kidney; Renal Insufficiency; Retrospective Studies | 2021 |
Reversible Deterioration in Hypophosphatasia Caused by Renal Failure With Bisphosphonate Treatment.
Topics: Alendronate; Densitometry; Diphosphonates; DNA Mutational Analysis; Fractures, Bone; Genetic Associa | 2015 |
Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure.
Topics: Adenine; Alendronate; alpha-Fetoproteins; Animals; Calcinosis; Chemical Precipitation; Liver; Male; | 2009 |
Mineral complexes and vascular calcification.
Topics: Adenine; Alendronate; alpha-Fetoproteins; Animals; Biomarkers; Calcinosis; Calcium; Chemical Precipi | 2009 |
Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
Topics: Acid Phosphatase; Aged; Alendronate; Biomarkers; Bone Resorption; Calcium; Diet; Female; Humans; Imm | 2004 |
Alendronate versus calcitriol for prevention of bone loss after cardiac transplantation.
Topics: Alendronate; Bone Density; Bone Resorption; Calcitriol; Creatinine; Cyclosporine; Female; Heart Tran | 2004 |
Renal function and bisphosphonate safety.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Creatinine; Fe | 2008 |